Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill maintains a Hold rating on Hims & Hers Health (NYSE:HIMS) and raises the price target from $16 to $23.
August 07, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank analyst George Hill maintains a Hold rating on Hims & Hers Health and raises the price target from $16 to $23.
The raised price target from $16 to $23 by Deutsche Bank indicates a positive outlook for Hims & Hers Health, which could lead to a short-term increase in stock price despite the Hold rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100